Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.4K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Multiple Allele Traits01:49

Multiple Allele Traits

38.4K
The Concept of Multiple Allelism
38.4K
Translation01:31

Translation

157.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
157.9K
Translation01:31

Translation

18.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
18.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

946
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
946
Hypoxia01:23

Hypoxia

2.3K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.3K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
Same author

When cure exists but access does not.

Nature medicine·2026
Same author

Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.

European journal of haematology·2026
Same author

Efficacy and Safety of Prophylaxis With a Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease-A WIL-31 Study Sub-Analysis.

European journal of haematology·2026
Same author

Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources.

The Lancet. Haematology·2026
Same author

Thalassemia and hypercoagulability.

Hematology. American Society of Hematology. Education Program·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Feb 25, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K

La talasemia

Ali T Taher1, David J Weatherall2, Maria Domenica Cappellini3

  • 1Department of Internal Medicine, American University of Beirut Medical Centre, Beirut, Lebanon.

Lancet (London, England)
|August 5, 2017
PubMed
Resumen
Este resumen es generado por máquina.

Los trastornos sanguíneos hereditarios como la talasemia y la enfermedad de células falciformes son condiciones genéticas comunes. La investigación explora nuevas terapias dirigidas a causas subyacentes como el desequilibrio de la cadena y la sobrecarga de hierro.

Más Videos Relacionados

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

Videos de Experimentos Relacionados

Last Updated: Feb 25, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
07:24

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

2.0K
Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
06:48

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome

Published on: March 23, 2022

2.8K
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

20.5K

Área de la Ciencia:

  • Hematología
  • La genética
  • Biología molecular

Sus antecedentes:

  • Los trastornos hereditarios de la hemoglobina, incluida la talasemia y la enfermedad de células falciformes, son enfermedades monogénicas prevalentes en todo el mundo.
  • Estos trastornos se manifiestan con relaciones desequilibradas de la cadena de globina, eritropoiesis ineficaz, anemia hemolítica crónica y complicaciones de sobrecarga de hierro.
  • El tratamiento actual incluye transfusiones, quelación de hierro y esplenectomía, con investigaciones en curso para nuevos tratamientos.

Objetivo del estudio:

  • Revisar la fisiopatología de los trastornos hereditarios de la hemoglobina.
  • Discutir las estrategias de gestión actuales.
  • Resaltar los enfoques terapéuticos emergentes dirigidos a los factores moleculares y patógenos.

Principales métodos:

  • Revisión de la literatura sobre los trastornos hereditarios de la hemoglobina.
  • Análisis de los mecanismos fisiopatológicos.
  • Evaluación de las estrategias terapéuticas actuales y nuevas.

Principales resultados:

  • Los trastornos hereditarios de la hemoglobina presentan una fisiopatología compleja que incluye desequilibrio de la cadena de globina y sobrecarga de hierro.
  • Los tratamientos convencionales como las transfusiones y la quelación son estándar pero tienen limitaciones.
  • Se están explorando nuevas vías terapéuticas para abordar los mecanismos subyacentes de la enfermedad.

Conclusiones:

  • Comprender la base molecular de los trastornos de la hemoglobina es crucial para desarrollar terapias específicas.
  • Los nuevos tratamientos tienen como objetivo corregir el desequilibrio de la cadena, mejorar la eritropoyesis y controlar la desregulación del hierro.
  • Las investigaciones en curso son prometedoras para mejorar los resultados de los pacientes con trastornos hereditarios de la hemoglobina.